Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARDS | MRNA | BMY | AMGN | GILD |
| Company | Aridis Pharmaceuticals Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0615 | 125.00 | 43.90 | 313.39 | 65.51 |
| High | 0.0640 | 126.40 | 44.33 | 322.60 | 65.53 |
| Low | 0.0590 | 122.01 | 43.69 | 308.68 | 64.33 |
| Last | 0.0615 | 125.00 | 43.99 | 311.29 | 64.78 |
| Change | +0.0025 | -0.59 | +0.29 | +32.90 | -0.55 |
| % Change | +4.24% | -0.47% | +0.66% | +11.82% | -0.84% |
| Volume | 28,900 | 4,513,100 | 12,104,400 | 9,644,601 | 7,822,700 |
| 20-Day Average Volume | 79,405 | 3,564,715 | 14,464,405 | 2,646,885 | 7,406,455 |
| Previous Close | 0.0590 | 125.59 | 43.70 | 278.39 | 65.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0651 | 108.49 | 47.46 | 272.27 | 66.88 |
| 20-Day Raw Stochastic | 25.00% | 87.09% | 7.87% | 81.73% | 8.01% |
| 20-Day Relative Strength | 44.22% | 68.06% | 29.25% | 72.10% | 30.11% |
| Weighted Alpha | -60.90 | +8.40 | -36.67 | +33.76 | -22.64 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Sell | 24% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 100% Buy | 88% Sell | 16% Sell | 100% Sell |
| Last Month's Opinion | 40% Sell | 56% Buy | 8% Sell | 24% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.38% since 04/26/24 | +15.77% since 04/26/24 | -1.92% since 04/26/24 | +15.30% since 04/26/24 | -0.98% since 04/26/24 |
| Low | 0.0566 on 04/29/24 | 108.72 on 04/29/24 | 43.33 on 05/02/24 | 268.99 on 04/29/24 | 64.33 on 05/03/24 |
| High | 0.0670 on 04/30/24 | 128.81 on 05/02/24 | 45.38 on 04/29/24 | 322.60 on 05/03/24 | 66.91 on 04/29/24 |
| 1-Month | |||||
| %Chg | -14.11% since 04/03/24 | +23.51% since 04/03/24 | -15.70% since 04/03/24 | +13.44% since 04/03/24 | -8.62% since 04/03/24 |
| Low | 0.0560 on 04/23/24 | 99.30 on 04/22/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 0.0799 on 04/04/24 | 128.81 on 05/02/24 | 52.08 on 04/04/24 | 322.60 on 05/03/24 | 71.39 on 04/04/24 |
| 3-Month | |||||
| %Chg | -22.35% since 02/02/24 | +28.21% since 02/02/24 | -9.69% since 02/02/24 | -3.68% since 02/02/24 | -15.83% since 02/02/24 |
| Low | 0.0560 on 04/23/24 | 84.06 on 02/13/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 0.0850 on 03/15/24 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 77.87 on 02/06/24 |
| 6-Month | |||||
| %Chg | -33.51% since 11/03/23 | +61.23% since 11/03/23 | -16.72% since 11/03/23 | +15.35% since 11/03/23 | -20.60% since 11/03/23 |
| Low | 0.0560 on 04/23/24 | 67.62 on 11/13/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 |
| High | 0.0960 on 11/07/23 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,828 | 48,085,900 | 88,584,272 | 149,321,728 | 81,340,888 |
| Shares Outstanding, K | 47,929 | 382,880 | 2,027,100 | 536,376 | 1,245,077 |
| Annual Sales | 3,090,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -30,370,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 420,000 | 2,811,000,000 | 11,865,000,000 | 8,196,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -80,000 | 217,000,000 | -11,911,000,000 | 767,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.08 | 1.57 | 0.45 | 0.60 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/06/23 | -3.07 on 05/02/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 06/13/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 42.10 | 14.87 | 16.26 |